- Involuntary Weight Loss: Interview With Lisa Capaldini, M.D.
This short overview looks at some of the major considerations in
treating involuntary weight loss of people with HIV, in 2005.
- Medicaid Cuts Alert
Here are some of the real problems of cutting cost by denying care,
instead of by improving the U.S. healthcare system, one of the most
inefficient in the world.
- Adult HIV Treatment Guidelines Updated
The U.S. HIV treatment guidelines were changed to include new drug
safety and interaction information, and to include a table on obtaining
new antiretrovirals not yet approved but available through expanded
access (which only includes tipranavir at this time).
- In-Depth Medical Reports on the Retroviruses Conference
The Clinical Care Options site now has six training modules
summarizing practical information for physicians, from the Retroviruses
conference in February.
- IOM: Nevirapine Study Is Reliable
The Institute of Medicine re-analyzed the key study that first
showed prevention of mother-to-child HIV transmission by single-dose
nevirapine. The IOM released a 150-page report concluding that the
study was properly conducted and its results are valid.
- DHEA Access Threatened?
DHEA came close to being totally banned in the U.S. in January 2005,
when a new law aimed at steroids in sports took effect. Even doctors
would not have been able to prescribe DHEA, and medical research on its
uses would have become far more difficult. A potentially important
treatment could have been lost for a long time -- and could still be
lost unless people are vigilant.
ISSN # 1052-4207
Copyright 2005 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.